EarningsQ3 2026 Earnings Report

AngioDynamics (UG2) Q3 2026 Earnings Report

1 Followers

DE:UG2 Q3 2026 EPS Results

Actual EPS€0.02

Consensus EPS-€0.10

Beat/MissBeat by +€0.12

One Year Ago EPS-€0.07

Actual Revenue€69.85M

Expected Revenue€68.38M

Beat/MissBeat by +€1.47M

YoY Revenue Growth+8.91%

QuarterQ3 2026

Date04/02/2026

TimeBefore Open

Conference CallThursday, April 2, 2026

DE:UG2 Upcoming Earnings

AngioDynamics's next earnings date is estimated for January 7, 2027, based on past reporting schedules.

DE:UG2 Q3 2026 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Jan 07, 2027	2027 (Q2)	-0.06 / -	0	―
Oct 08, 2026	2027 (Q1)	-0.10 / -0.04	-0.089	60.00% (+0.05)
Jul 14, 2026	2026 (Q4)	-0.08 / -0.06	-0.027	-133.33% (-0.04)
Apr 02, 2026	2026 (Q3)	-0.10 / 0.02	-0.071	125.00% (+0.09)
Jan 06, 2026	2026 (Q2)	-0.09 / 0.00	-0.036	―
Oct 02, 2025	2026 (Q1)	-0.11 / -0.09	-0.098	9.09% (<+0.01)
Jul 15, 2025	2025 (Q4)	-0.11 / -0.03	-0.053	50.00% (+0.03)
Apr 02, 2025	2025 (Q3)	-0.12 / -0.07	-0.143	50.00% (+0.07)
Jan 08, 2025	2025 (Q2)	-0.10 / -0.04	-0.045	20.00% (<+0.01)
Oct 03, 2024	2025 (Q1)	-0.13 / -0.10	-0.107	8.33% (<+0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed